Serum Soluble Programme Death-1 and Programme Death- Ligand 1 Identify Multiple Myeloma Patients: Serum sPDL-1 May Be a Prognostic Marker


Creative Commons License

TERZİ DEMİRSOY E., BİRTAŞ ATEŞOĞLU E., TARKUN P., MEHTAP Ö., GEDÜK A., HACİHANİFİOĞLU A.

Eurasian Journal of Medical Investigation, 2019 (Hakemli Dergi)